Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Public health risks from potable water supply disruptions during drought in high-income countries: A scoping review and policy implications for the United Kingdom.

International journal of hygiene and environmental health·2026
Same author

Publisher Correction: A 98-qubit trapped-ion quantum computer with all-to-all connectivity.

Nature·2026
Same author

Evaluation of TIMS-derived peptide mobility measurements: calibration strategy and MS1/MS2 discrepancies.

Analytical and bioanalytical chemistry·2026
Same author

A 98-qubit trapped-ion quantum computer with all-to-all connectivity.

Nature·2026
Same author

Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α.

Journal of medicinal chemistry·2026
Same author

The why behind the how: The association between motive and strategy use in interpersonal emotion regulation.

Emotion (Washington, D.C.)·2026

Related Experiment Video

Updated: Jun 15, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Optimizing QACT Frequency and Setup Uncertainty in Cranial Proton Therapy for Normal Tissue Sparing.

Rachel B Ger1, Anh Tran1, Victoria J Croog1

  • 1Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

International Journal of Particle Therapy
|June 13, 2025
PubMed
Summary

Proton therapy cranial treatments can be optimized by reducing setup uncertainty to 2 mm, ensuring robust target coverage and organ at risk sparing. Tailored quality assurance computed tomography (QACT) schedules based on beam trajectory minimize unnecessary imaging.

Keywords:
Cranial tumorsProton therapyRobustnessSetup uncertainty

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Related Experiment Videos

Last Updated: Jun 15, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Area of Science:

  • Medical Physics
  • Radiation Oncology

Background:

  • Proton therapy offers precise cranial dose distributions but is sensitive to setup variations.
  • Quality assurance computed tomography (QACT) scans improve accuracy but increase patient dose and workflow burden.
  • Optimal setup uncertainty margins and QACT frequencies require further investigation for robust cranial proton therapy.

Purpose of the Study:

  • To evaluate the dosimetric robustness of cranial proton therapy with reduced setup uncertainty.
  • To assess the impact of setup uncertainty on target coverage and organ at risk (OAR) sparing.
  • To inform adaptive planning and QACT frequency requirements based on beam trajectory and target location.

Main Methods:

  • Retrospective review of 122 adult patients treated with cranial proton therapy (2019-2023).
  • Analysis of adaptive planning rates based on beam paths through the neck or nasal cavity.
  • Re-planning of 20 selected patients using 2 mm setup uncertainty versus the clinical 3 mm standard, with synthetic CT generation for daily verification.

Main Results:

  • Only 6 patients required adaptive plans, with 2 cases attributed to anatomical changes in patients with beams traversing the nasal cavity.
  • Clinical target volume (CTV) coverage goals were met in 95.7% (2 mm) and 99.6% (3 mm) of plans.
  • Overall clinical goals were met in 99.3% for both 2 mm and 3 mm uncertainty plans, with minimal dose deviations.

Conclusions:

  • A 2 mm setup uncertainty margin provides robust target coverage and OAR sparing in cranial proton therapy.
  • Tailored QACT schedules, considering beam trajectory and target location, can reduce imaging burden without compromising accuracy.
  • Proton therapy protocols can be refined by implementing reduced setup margins and selective QACT based on patient-specific factors.